You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ribociclib

Showing 26 - 50 of 78
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting
  • Advanced Soft Tissue Sarcoma
  • +26 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 6, 2023

Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)

Completed
Has Results
  • Breast Cancer
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 13, 2022

Breast Cancer Trial in Worldwide (Docetaxel / Capecitabine, Capecitabine / Vinorelbine, Paclitaxel / Gemcitabine)

Active, not recruiting
  • Breast Cancer
  • Docetaxel / Capecitabine
  • +5 more
  • Cairo, Egypt
  • +51 more
Oct 24, 2022

Breast Cancer Trial in United States (Letrozole, Ribociclib, Placebo)

Active, not recruiting
  • Breast Cancer
  • Little Rock, Arkansas
  • +12 more
Sep 24, 2022

Breast Cancer Trial (Ribociclib)

No longer available
  • Breast Cancer
  • Ribociclib
  • (no location specified)
Feb 15, 2022

Breast Cancer, Breast Tumors, Breast Tumor Female Trial in Germany (Ribociclib)

Not yet recruiting
  • Breast Cancer
  • +6 more
  • Ribociclib
  • Erlangen, Bavaria, Germany
  • +15 more
Aug 10, 2022

Glioblastoma Multiforme, Meningioma Trial in Phoenix (Ribociclib)

Recruiting
  • Glioblastoma Multiforme
  • Meningioma
  • Ribociclib
  • Phoenix, Arizona
    Barrow Brain and Spine
Oct 7, 2021

Breast Cancer Trial in United States (ARV-471, Ribociclib)

Not yet recruiting
  • Breast Cancer
  • Shiloh, Illinois
  • +8 more
Feb 1, 2023

Breast Cancer, Metastatic Breast Cancer Trial (Elacestrant, Alpelisib, Everolimus)

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • (no location specified)
Sep 28, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Phoenix, Jacksonville, Rochester (Gemcitabine

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Gemcitabine Hydrochloride
  • +3 more
  • Phoenix, Arizona
  • +2 more
Oct 6, 2021

Non-small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, Esophageal SCC Trial in Worldwide (TNO155, Spartalizumab,

Recruiting
  • Non-small Cell Lung Carcinoma
  • +4 more
  • Boston, Massachusetts
  • +8 more
Mar 18, 2022

Cancer Trial in Melbourne (Trametinib, Cobimetinib, Binimetinib)

Recruiting
  • Cancer
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Nov 4, 2022

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

Not yet recruiting
  • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
  • (no location specified)
Sep 26, 2023

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +19 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 11, 2022

Breast Tumor, Metastatic Breast Cancer, Rb+ Breast Cancer Trial in Philadelphia ([18F]FLT, PET/CT, ribociclib)

Active, not recruiting
  • Breast Neoplasm
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Aug 16, 2022

Neuroblastoma, Cancer Trial in Philadelphia (procedure, genetic, other, behavioral, drug)

Terminated
  • Neuroblastoma
  • Cancer
  • Biopsy
  • +12 more
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Jan 31, 2023

Breast Cancer Trial in Sweden (Trastuzumab deruxtecan, Docetaxel, Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan
  • +9 more
  • Malmö, Sweden
  • +6 more
Jun 8, 2023

PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

Not yet recruiting
  • PIK3CA Mutation
  • +7 more
  • (no location specified)
Mar 7, 2023

Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma, Metastatic Malignant

Withdrawn
  • Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
  • +3 more
  • (no location specified)
Oct 13, 2021

EGFR-mutant NSCLC Trial in Worldwide (EGF816, trametinib, ribociclib)

Active, not recruiting
  • EGFR-mutant Non-small Cell Lung Cancer
  • Toronto, Ontario, Canada
  • +10 more
Dec 5, 2022

Low Grade Serous Carcinoma Trial in United States (Ribociclib, Letrozole)

Recruiting
  • Low Grade Serous Carcinoma
  • San Francisco, California
  • +26 more
Feb 15, 2022

Collect Data on Efficacy and Safety of RIBociclib in Older

Recruiting
  • Breast Cancer
  • Ribociclib
  • Leuven, Belgium
    UZ Gasthuisberg Leuven
Mar 17, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

HER2-negative and Hormone-receptor Positive Metastatic Breast Cancer, HER2-negative Circulating Tumor Cells, Postmenopausal

Active, not recruiting
  • HER2-negative and Hormone-receptor Positive Metastatic Breast Cancer
  • +2 more
  • Ulm, Baden-Württemberg, Germany
    University Hospital Ulm -Department of Gynecology
Jul 27, 2022

Breast Cancer Trial in Italy (Ribociclib, Letrozole, Alpelisib)

Active, not recruiting
  • Breast Cancer
  • Ribociclib
  • +3 more
  • Casale Monferrato, AL, Italy
  • +40 more
Dec 3, 2021